| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/26/2006 | CN1762428A Method for extracting efficient component from mulberry leaf |
| 04/26/2006 | CN1762415A Astragalus root pills formula and its preparation method |
| 04/26/2006 | CN1762380A Nano selenium product and its preparation method |
| 04/26/2006 | CN1762374A Gypenosides pills formula and its preparation method |
| 04/26/2006 | CN1762367A Ursodeoxycholic acid pills formula and its preparation method |
| 04/26/2006 | CN1762361A Pharmaceutical composition containing amiodipine besylate and rosuvastatin calcium, and its preparation method |
| 04/26/2006 | CN1762356A Pharmaceutical composition and its application in preparation of medicine for treating type II diabetes |
| 04/26/2006 | CN1762343A EGCG-zinc complex solid dispersion, its preparation method and application |
| 04/26/2006 | CN1762325A Toxic and side effect-free externally-applied health-care cream for removing wrinkle, caring skin and keeping fitness |
| 04/26/2006 | CN1253463C Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 04/26/2006 | CN1253455C 2-3-methylen-dioxy dibenzo [a,g] quinolizine onium hydrochloride and its uses in treatment of diabete |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/26/2006 | CN1253204C Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 04/26/2006 | CN1253190C Medicine for treating diabetes |
| 04/26/2006 | CN1253183C Prescription of weight-reducing and health-care preparation |
| 04/26/2006 | CN1253164C Novel use of tuber fleeceflower stem extract |
| 04/26/2006 | CN1253145C Blood sugar reducing skin-care cream specially for curing diabetes and its producing method |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034111 17867, a novel human aminopeptidase |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7033623 Mineral absorption enhancer |
| 04/25/2006 | US7033616 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use |
| 04/25/2006 | CA2522899C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521956C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1-h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521908C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521891C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521887C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521833C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521828C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521792C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521776C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2493827A1 Natural product derivatives as food supplements and pharmaceuticals |
| 04/25/2006 | CA2438097C Cannabinoids pharmaceutical formulations |
| 04/25/2006 | CA2126929C Non-reducing oligosaccharide and its production and use |
| 04/21/2006 | CA2493831A1 Amino acid esters as nutrient supplements and methods of use |
| 04/21/2006 | CA2493398A1 Nutritional and food supplement preparation comprising creatine and orotic acid complexes, derivatives and analogs |
| 04/20/2006 | WO2006041976A1 Combination of organic compounds |
| 04/20/2006 | WO2006041197A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/20/2006 | WO2006041158A1 Method for modifying the ambience, and spray liquid and sprayer used in the method |
| 04/20/2006 | WO2006041150A1 Preventive and/or therapeutic agent for diabetes |
| 04/20/2006 | WO2006041046A1 Pyridine derivative |
| 04/20/2006 | WO2006041021A1 Drug for diminishing increase of neutral fat in blood after meal and food containing the same |
| 04/20/2006 | WO2006040966A1 Aromatic-ring-fused pyrimidine derivative |
| 04/20/2006 | WO2006040914A1 Process for producing concentrate of unsaturated fatty acid |
| 04/20/2006 | WO2006040464A1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide |
| 04/20/2006 | WO2006040329A1 1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | WO2006018708A3 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 04/20/2006 | WO2005062897A3 Polymorphs of ezetimibe and processes for the preparation thereof |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084702 (2S)-2-ethylphenylpropionic acid derivative |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084663 Alkanoic acids, nitriles and amides substituted with a group containing benzene ring linked through a thiazolyl- or oxazolyl- phenyl group; e.g., {4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2-propyl-phenoxy}-acetic acid; treating diabetes and atherosclerosis |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084618 Adiponectin promoter and use thereof |
| 04/20/2006 | US20060084597 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity |
| 04/20/2006 | US20060084112 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states |
| 04/20/2006 | US20060084109 Regulated aptamer therapeutics |
| 04/20/2006 | US20060083790 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083733 High-concentration preparation of soluble thrombomodulin |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | DE102004050353A1 Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen Using stable ammonium salts of lipoic acid in the treatment of diabetic and other disorders |
| 04/20/2006 | DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts |
| 04/20/2006 | CA2584709A1 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
| 04/20/2006 | CA2581781A1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide |
| 04/20/2006 | CA2580266A1 Combination of organic compounds |
| 04/19/2006 | EP1647555A1 The c-glycosylisoflavones having alkylaminoalkoxyl substituent, the preparation and the use of the same |
| 04/19/2006 | EP1647546A1 Novel heteroaryl derivative |
| 04/19/2006 | EP1647273A1 Ophthalmic composition |
| 04/19/2006 | EP1646628A1 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 04/19/2006 | EP1646626A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1646625A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 04/19/2006 | EP1646390A1 A1 adenosine receptor antagonists |
| 04/19/2006 | EP1646374A1 Extended-release tablets of metformin |
| 04/19/2006 | EP1572708B1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 04/19/2006 | EP1572198B1 New pharmaceutical compounds with alpha2receptor activity |
| 04/19/2006 | EP1556140A4 Novel compounds |
| 04/19/2006 | EP1545562B1 Branched alpha-glucans for weight management |
| 04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 04/19/2006 | EP1492569A4 Aqueous dispersible steryl ester compositions |
| 04/19/2006 | EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |